12:00 AM
 | 
Oct 01, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

CYT997: Development discontinued

YM BioSciences disclosed in its 4Q12 earnings for the year ended June 30 that it discontinued development of CYT997. The biotech said the decision is based on preclinical data...

Read the full 122 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >